Literature DB >> 29218065

Acute Myocardial Injury in a Child with Duchenne Muscular Dystrophy: Pulse Steroid Therapy?

Eliza Cinteza1, Claudiu Stoicescu2, Niculina Butoianu3, Mihaela Balgradean1, Alin Nicolescu1, Matthias Angrés1.   

Abstract

Heart implication in Duchenne muscular dystrophy usually is present in the form of dilated cardiomyopathy, manifested as heart failure and arrhythmias. To delay progression, including heart deterioration, prednisone is recommended as preventive treatment. We report the case of an 11-year-old boy diagnosed with Duchenne muscular dystrophy at the age of seven, who was on preventive treatment with oral prednisone (0.75 mg/kg/day) and beta blocker (metoprolol, 1 mg/kg/day). Suddenly, the patient presented acute chest pain, vomiting and sweating. The electrocardiogram showed ST elevation in inferior leads. Troponin T was increased to 30814 pg/ml (normal values <14 pg/mL). The echocardiography revealed reduced contractility of the posteroinferior wall of the left ventricle. After excluding coronary implications by coronary angiography, we increased the oral prednisone to 1.4 mg/kg/day for five days and added enalapril (0.5 mg/kg/day, po). The response was positive, with a rapid decrease of the troponin T value to 3186 pg/mL in five days and gradual recovery of myocardial contractility afterwards.

Entities:  

Year:  2017        PMID: 29218065      PMCID: PMC5706757     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  12 in total

1.  Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Authors:  Elizabeth M McNally; Jonathan R Kaltman; D Woodrow Benson; Charles E Canter; Linda H Cripe; Dongsheng Duan; Jonathan D Finder; William J Groh; Eric P Hoffman; Daniel P Judge; Naomi Kertesz; Kathi Kinnett; Roxanne Kirsch; Joseph M Metzger; Gail D Pearson; Jill A Rafael-Fortney; Subha V Raman; Christopher F Spurney; Shari L Targum; Kathryn R Wagner; Larry W Markham
Journal:  Circulation       Date:  2015-05-05       Impact factor: 29.690

Review 2.  [Update of steroid therapy for Duchenne muscular dystrophy].

Authors:  Fumi Takeuchi; Hirofumi Komaki
Journal:  No To Hattatsu       Date:  2015-07

3.  Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.

Authors:  Hidemi Kajimoto; Keiko Ishigaki; Kenichi Okumura; Hirofumi Tomimatsu; Makoto Nakazawa; Kayoko Saito; Makiko Osawa; Toshio Nakanishi
Journal:  Circ J       Date:  2006-08       Impact factor: 2.993

4.  Long-Term Steroid Therapy in Duchenne Muscular Dystrophy-Positive Results versus Side Effects.

Authors:  U Schara; W Mortier
Journal:  J Clin Neuromuscul Dis       Date:  2001-06

Review 5.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

Review 6.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

7.  All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy.

Authors:  Gernot Schram; Anne Fournier; Hugues Leduc; Nagib Dahdah; Johanne Therien; Michel Vanasse; Paul Khairy
Journal:  J Am Coll Cardiol       Date:  2013-01-23       Impact factor: 24.094

8.  [Acute myocardial infarction in a 13-year-old boy with Duchenne's disease].

Authors:  C Cuccia; G Benedini; O Leonzi; N Pagnoni; R Giubbini
Journal:  G Ital Cardiol       Date:  1984-10

9.  Myocardial infarction in a child aged ten with Duchenne muscular dystrophy.

Authors:  F Fiorista; G Brambilla; M Saviotti; T Diaco; M Morpurgo
Journal:  Z Kardiol       Date:  1981-10

10.  Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.

Authors:  Vincenzo Giglio; Paolo Emilio Puddu; Giovanni Camastra; Stefano Sbarbati; Sabino Walter Della Sala; Alessandra Ferlini; Francesca Gualandi; Enzo Ricci; Federico Sciarra; Gerardo Ansalone; Marco Di Gennaro
Journal:  J Cardiovasc Magn Reson       Date:  2014-07-09       Impact factor: 5.364

View more
  4 in total

1.  Troponin I Levels Correlate with Cardiac MR LGE and Native T1 Values in Duchenne Muscular Dystrophy Cardiomyopathy and Identify Early Disease Progression.

Authors:  Sonia Voleti; Laura Olivieri; Karin Hamann; Heather Gordish-Dressman; Christopher Spurney
Journal:  Pediatr Cardiol       Date:  2020-05-31       Impact factor: 1.655

2.  ST-elevation myocardial infarction in a young patient with Duchenne's muscular dystrophy: a case report.

Authors:  Panagiota Mitropoulou; Alexander Hobson; Geraint Morton; Brijesh Anantharam
Journal:  Eur Heart J Case Rep       Date:  2022-05-16

Review 3.  Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel.

Authors:  Christopher F Spurney; Deborah Ascheim; Lawrence Charnas; Linda Cripe; Kan Hor; Nicholas King; Kathi Kinnett; Elizabeth M McNally; John-Michael Sauer; Lee Sweeney; Chet Villa; Larry W Markham
Journal:  Open Heart       Date:  2021-03

4.  Chest Pain and Electrocardiographic Changes in a Child With Duchenne Muscular Dystrophy.

Authors:  Hanan Salah Al Hajri; Eman Mahmoud El Husseiny; Hasan Qayyum
Journal:  Cureus       Date:  2022-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.